PCI Pharma Services has completed the expansion of its Clinical Services Center of Excellence in Bridgend, UK and has begun moving into the expansion for progression to full validation.

The new storage and distribution facility will provide PCI with additional space to complement its existing footprint for specialist clinical trial logistics as well as packaging, labeling and Qualified Person activities for investigational medicinal products.

Work on the expansion began last year, and internal fit-out works are now underway. Full completion is scheduled for September 2017, with the facility set to be validated and operational by January 2018.

PCI now has 70 employees in Bridgend, where it has been since 2007, occupying 11,000-square-feet at Biotec House and later expanding five years later into a custom-built 22,000-square-foot space in neighboring units 2010 and 2130.

The latest addition to its Clinical Services Center of Excellence provides a high-spec unit with warehouse and office space across two floors, purpose-built to support specialist secondary packaging, storage, and logistical needs. It also provides scope for further expansion in the future with an option for a further addition to the new building.

Th most recent expansion at Bridgend is the latest in a series of investments by PCI in developing its presence at the site, including a purpose-built and dedicated -40°C facility, as well as a broader cold-chain capacity expansion that increased site storage by over 400%, and expansion of frozen storage at -80°C. The new building sits adjacent to these current facilities. These investments at Bridgend mirror PCI investments at its other European and North American sites for clinical-trial services.

Source: PCI Pharma Services